Richard G. Vincent

Companies

• Forte Biosciences, Inc.Board member Sep 19, 2024 to now¹
• Oncternal Therapeutics, Inc.Chief financial officer Jun 11, 2019 to Feb 15, 2024²
• Sorrento TherapeuticsOfficer Oct 9, 2014 to Oct 9, 2014³
• Sorrento TherapeuticsBoard member Sep 25, 2012 to Oct 31, 2013⁴
• Sorrento TherapeuticsChief financial officer Feb 9, 2010 to Oct 31, 2013⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• OTOncternal Therapeutics, Inc.142,756 shares⁶Jan 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 3, 2024Shares withheld for tax 8,868 shares at $0.50 of Oncternal Therapeutics, Inc.⁶
• Jul 3, 2023Shares withheld for tax 7,069 shares at $0.36 of Oncternal Therapeutics, Inc.⁷
• Apr 13, 2023Bought 30,000 shares at $0.30 of Oncternal Therapeutics, Inc.⁸
• Jan 3, 2023Shares withheld for tax 4,428 shares at $1.02 of Oncternal Therapeutics, Inc.⁹
• Jul 28, 2022Granted 43,125 shares of Oncternal Therapeutics, Inc.¹⁰
• Mar 28, 2022Bought 2,500 shares at $1.40 of Oncternal Therapeutics, Inc.¹¹
• Mar 25, 2022Bought 2,136 shares at $1.49 of Oncternal Therapeutics, Inc.¹¹
• Mar 25, 2022Bought 5 shares at $1.48 of Oncternal Therapeutics, Inc.¹¹
• Mar 25, 2022Bought 356 shares at $1.45 of Oncternal Therapeutics, Inc.¹¹
• Mar 24, 2022Bought 3 shares at $1.45 of Oncternal Therapeutics, Inc.¹¹
• Jan 28, 2022Bought 2,500 shares at $1.65 of Oncternal Therapeutics, Inc.¹²
• Jan 27, 2022Bought 5,000 shares at $1.70 of Oncternal Therapeutics, Inc.¹²
• Jan 27, 2022Bought 5,000 shares at $1.80 of Oncternal Therapeutics, Inc.¹²
• Jan 3, 2022Granted 29,867 shares of Oncternal Therapeutics, Inc.¹³